US FDA investigates death tied to Takeda's blood disorder drug

Core Insights - The U.S. Food and Drug Administration (FDA) is investigating the death of a patient who developed harmful antibodies after using Takeda Pharmaceuticals' blood disorder drug [1] Company Summary - Takeda Pharmaceuticals is facing scrutiny from the FDA due to a reported patient death linked to its blood disorder medication [1]